Cargando…
Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC
The infectious diseases caused by multidrug-resistant bacteria pose serious threats to humankind. It has been suggested that an antibiotic targeting LpxC of the lipid A biosynthetic pathway in Gram-negative bacteria is a promising strategy for curing Gram-negative bacterial infections. However, expe...
Autores principales: | Lemaître, Nadine, Liang, Xiaofei, Najeeb, Javaria, Lee, Chul-Jin, Titecat, Marie, Leteurtre, Emmanuelle, Simonet, Michel, Toone, Eric J., Zhou, Pei, Sebbane, Florent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527309/ https://www.ncbi.nlm.nih.gov/pubmed/28743813 http://dx.doi.org/10.1128/mBio.00674-17 |
Ejemplares similares
-
The nucleotide-binding site of Aquifex aeolicus LpxC
por: Buetow, Lori, et al.
Publicado: (2006) -
Drug design from the cryptic inhibitor envelope
por: Lee, Chul-Jin, et al.
Publicado: (2016) -
Interplay of Klebsiella pneumoniae
fabZ and lpxC Mutations Leads to LpxC Inhibitor-Dependent Growth Resulting from Loss of Membrane Homeostasis
por: Mostafavi, Mina, et al.
Publicado: (2018) -
Regulated Expression of lpxC Allows for Reduction of Endotoxicity in Bordetella pertussis
por: Pérez-Ortega, Jesús, et al.
Publicado: (2022) -
LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens
por: Tomaras, Andrew P., et al.
Publicado: (2014)